ArticleJMIR human factors2025
Usability and User Experience Testing of a Co-Designed Electronic Patient-Reported Outcomes App ("MyPal for Adults") for Palliative Cancer Care: Mixed Methods Study.
Article in JMIR human factors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- SiMON-PRO-Hematology®: Digital techology for pharmacotherapeutic and patient reported outcomes monitoring in patients with hematologic malignancies.Exploratory research in clinical and social pharmacy · 2026Article
- Development of an electronic system for self/proxy symptom tracking alongside children with cancer and their caregivers: a co-design exemplar.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mobile health technologies have the potential to enhance the management, communication, and overall quality of life of patients with cancer. The MyPal project, using a participatory design approach, aims to provide palliative care support for patients with cancer through an electronic patient-reported outcomes eHealth platform. Objective: This study aims to evaluate the usability and user experience of "MyPal for adults," a co-designed palliative care mobile app designed to support adults with cancer. Methods: Representative users participated in a 4-step usability study using a "think-aloud" protocol, complemented with feature satisfaction, difficulty perceived, and design impression surveys along with a short, structured interview. Participants were also asked to provide quantitative feedback via the postuse System Usability Scale, User Experience Questionnaire, and Post-Study System Usability Questionnaire. The data were analyzed along the lines of the International Organization for Standardization (ISO) 9241-210 framework. Results: All participants found the intervention content useful, and they reported satisfactory usability, with a mean Post-Study System Usability Questionnaire score of 2.458 (SD 1.08) and a System Usability Scale score of 68.9. All aspects of the User Experience Questionnaire (attractiveness, perspicuity, efficiency, dependability, stimulation, and novelty) surpassed usability quality benchmarks. The qualitative analysis identified 43 usability issues, primarily related to effectiveness and efficiency as defined in ISO 9241-210. Conclusions: In this study, we conducted a usability evaluation of the "MyPal for adults" app, a digital tool designed to enhance the palliative care experience. This approach identifies real-world usability issues, enabling iterative improvements in the eHealth platform's design. Our findings reveal a user-friendly interface and positive patient experiences. This study emphasizes the need to enhance mobile health platform usability, offering insights to improve digital palliative care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.